S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
ETR:EVD

CTS Eventim AG & Co. KGaA (EVD) Stock Price, News & Analysis

€82.50
+1.65 (+2.04%)
(As of 04/18/2024 ET)
Today's Range
€80.65
€83.00
50-Day Range
€66.45
€85.35
52-Week Range
€52.30
€86.30
Volume
152,936 shs
Average Volume
148,299 shs
Market Capitalization
$7.92 billion
P/E Ratio
28.85
Dividend Yield
1.73%
Price Target
N/A
EVD stock logo

About CTS Eventim AG & Co. KGaA Stock (ETR:EVD)

CTS Eventim AG & Co. KGaA operates in the leisure events market in Germany, Italy, Switzerland, Austria, the United Kingdom, Sweden, the United States, Finland, Spain, Denmark, the Netherlands, and internationally. The company operates through two segments, Ticketing and Live Entertainment. The Ticketing segment produces, sells, brokers, distributes, and markets tickets for concerts, theatre, art, sports, and other events. It markets events (tickets) through EVENTIM.Web and using its network platform, EVENTIM.Net; in-house ticketing products through EVENTIM.Inhouse; sport ticketing products through EVENTIM.Tixx; and self-service products for promotors through EVENTIM.Light, as well as provides a solution for ticket sales and admission control through EVENTIM.Access. This segment also operates kinoheld software for cinema operators; EVENTIM.fanSALE, a resale portal where customers sell event tickets to other customers; and online portals under various brands, such as eventim.de, oeticket.com, ticketcorner.ch, ticketone.it, and entradas.com. The Live Entertainment segment plans, prepares, and performs tours, events, and festivals, including music events and concerts, as well as markets music productions. This segment is also involved in the operation of venues. The company was formerly known as CTS EVENTIM AG and changed its name to CTS Eventim AG & Co. KGaA in May 2014. CTS Eventim AG & Co. KGaA was founded in 1989 and is headquartered in Bremen, Germany.

EVD Stock Price History

EVD Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CTS Eventim AG & Co. KGaA
CTS Eventim AG & Co. KGaA EVD
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CTS Eventim AG & Co. KGaA (EVD0.MU)
Cred Ag Co 30 Share Chat
CTS Eventim AG & Co. KGaA ADR
CTS Eventim H1 Normalised EBITDA, Revenues Climb; Sees Growth In FY23
PROCREDIT HOLDING AG & CO KGAA
CTS Eventim AG & Co. KGaA Just Beat Revenue Estimates By 82%
CTS Eventim AG (EVDG)
See More Headlines
Receive EVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CTS Eventim AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Entertainment
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3,535
Year Founded
N/A

Profitability

Net Income
$274.64 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.36 billion
Cash Flow
€13.61 per share
Book Value
€9.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$7.92 billion
Optionable
Not Optionable
Beta
1.24
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Klaus-Peter Schulenberg
    Chairman of Management Board & CEO
  • Mr. Betriebswirt Christian Alexander Ruoff
    COO & Member of Management Board
  • Mr. Holger Hohrein (Age 53)
    Chief Financial Officer & Member of Management Board
  • Mr. Marco Haeckermann
    Vice President Corporate Development & Strategy

EVD Stock Analysis - Frequently Asked Questions

How have EVD shares performed in 2024?

CTS Eventim AG & Co. KGaA's stock was trading at €62.60 on January 1st, 2024. Since then, EVD shares have increased by 31.8% and is now trading at €82.50.
View the best growth stocks for 2024 here
.

Is CTS Eventim AG & Co. KGaA a good dividend stock?

CTS Eventim AG & Co. KGaA (ETR:EVD) pays an annual dividend of €1.43 per share and currently has a dividend yield of 1.74%. The dividend payout ratio is 50.00%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of CTS Eventim AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CTS Eventim AG & Co. KGaA investors own include Novo Nordisk A/S (NVO), SVMK (SVMK), AbbVie (ABBV), Beazley (BEZ), Warner Bros. Discovery (DISCK), Genpact (G), General Electric (GE), Marks and Spencer Group (MKS), NIKE (NKE) and Old Dominion Freight Line (ODFL).

This page (ETR:EVD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners